Fund Holdings — ACORN CAPITAL ADVISORS, LLC

Total Portfolio Value:
$351.84M
Total Bought:
$23.74M
Total Sold:
$41.25M
Net Transaction:
-$17.52M
Securities
▲▼
SharesValue
Q4 2025
▲▼
Q1 2026
▲▼
Change
▲▼
Q4 2025
▲▼
Q1 2026
▲▼
Weight (%)
▲▼
Change
▲▼
Terns Pharmaceuticals Inc1,746,2641,746,2640$70.55M$92.06M26.17%+$21.51M
CG Oncology, Inc.(CGON)1,131,5011,130,501-1,000$46.98M$76.58M21.77%+$29.60M
UroGen Pharma Ltd.(URGN)1,448,4201,673,420+225,000$33.92M$30.09M8.55%-$3.83M
Puma Biotechnology, Inc.(PBYI)4,131,2994,131,2990$24.58M$26.40M7.50%+$1.82M
Trevi Therapeutics, Inc.(TRVI)2,144,8442,144,8440$26.85M$25.59M7.27%-$1.27M
Candel Therapeutics, Inc.(CADL)2,580,5173,497,948+917,431$14.58M$17.21M4.89%+$2.63M
Bicara Therapeutics643,382643,3820$10.83M$12.80M3.64%+$1.97M
OnKure Therapeutics, Inc.CL A(OKUR)2,839,6742,839,6740$8.24M$11.76M3.34%+$3.52M
Jade Biosceinces Inc0786,760+786,760$0$11.05M3.14%+$11.05M
Protara Therapeutics, Inc.(TARA)1,752,1151,752,1150$9.34M$9.13M2.59%-$210.3K
Verastem, Inc.(VSTM)1,469,1531,469,1530$11.34M$7.79M2.21%-$3.56M
Cybin D/B/A Helus Pharma(HELP)1,573,0231,540,266-32,757$12.87M$7.39M2.10%-$5.48M
LeonaBio, Inc.(LONA)501,739634,539+132,800$3.80M$6.52M1.85%+$2.72M
Aura Biosciences, Inc.(AURA)595,744595,7440$3.25M$3.99M1.13%+$738.7K
Whitehawk Therapeutics, Inc.(WHWK)1,139,3631,139,3630$2.76M$3.93M1.12%+$1.17M
Cardiff Oncology, Inc.(CRDF)1,962,0841,762,084-200,000$5.51M$2.85M0.81%-$2.66M
Q32 Bio Inc.(QTTB)493,425315,052-178,373$1.64M$2.02M0.57%+$384.5K
Karyopharm Therapeutics Inc.(KPTI)0287,826+287,826$0$1.60M0.46%+$1.60M
Jasper Therapeutics, Inc.(JSPR)1,786,4921,411,492-375,000$3.27M$1.24M0.35%-$2.03M
X4 Pharmaceuticals, Inc.(XFOR)273,349234,039-39,310$1.09M$966.6K0.27%-$126.8K
BioAtla, Inc.(BCAB)4,835,1115,406,345+571,234$2.76M$865.0K0.25%-$1.89M
Yarrow Bioscience Inc(YARW)1,4251,4250$827$8550.00%+$28
Acrivon Therapeutics Inc405,2370-405,237$976.6K$0—-$976.6K
Page 1 of 1
ACORN CAPITAL ADVISORS, LLC — 13F Holdings — Q1 2026 | TickerTrail